Century Therapeutics Inc. (IPSC) NASDAQ
$4.27 0.29 (7.29%)
Market Cap: $276.77M
As of 03/27/24 04:00 PM EDT. Market closed.
Century Therapeutics Inc. (IPSC)
NASDAQ
$4.27
0.29 (7.29%)
Market Cap: $276.77M
As of 03/27/24 04:00 PM EDT. Market closed.
Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research ... read more
Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Farid Adrienne | Chief Operations Officer | Mar 07, 2024 | Option Exercise | $1.03 | 22,831 | 23,516 | 136,980 | Mar 08, 2024, 06:29 PM |
Farid Adrienne | Chief Operations Officer | Mar 06, 2024 | Option Exercise | $1.03 | 30,684 | 31,605 | 144,833 | Mar 08, 2024, 06:29 PM |
Farid Adrienne | Chief Operations Officer | Mar 07, 2024 | Sale | $5.14 | 22,831 | 117,342 | 114,149 | Mar 08, 2024, 06:29 PM |
Farid Adrienne | Chief Operations Officer | Mar 06, 2024 | Sale | $4.96 | 30,684 | 152,340 | 114,149 | Mar 08, 2024, 06:29 PM |
Farid Adrienne | Chief Operations Officer | Feb 16, 2024 | Option Exercise | $1.03 | 485 | 500 | 114,634 | Feb 21, 2024, 04:10 PM |
Farid Adrienne | Chief Operations Officer | Feb 16, 2024 | Sale | $4.86 | 485 | 2,358 | 114,149 | Feb 21, 2024, 04:10 PM |
Carr Douglas | SVP Finance & Operations | Feb 06, 2024 | Sale | $4.49 | 557 | 2,499 | 303,580 | Feb 07, 2024, 05:21 PM |
Carr Douglas | SVP Finance & Operations | Feb 05, 2024 | Sale | $3.84 | 643 | 2,470 | 304,137 | Feb 07, 2024, 05:21 PM |
Farid Adrienne | Chief Operations Officer | Feb 06, 2024 | Sale | $4.49 | 1,784 | 8,005 | 114,149 | Feb 07, 2024, 05:21 PM |
Farid Adrienne | Chief Operations Officer | Feb 05, 2024 | Sale | $3.84 | 2,035 | 7,816 | 115,933 | Feb 07, 2024, 05:21 PM |
Carr Douglas | SVP Finance & Operations | Nov 01, 2023 | Option Exercise | $1.49 | 16,611 | 24,750 | 304,780 | Nov 03, 2023, 04:04 PM |
Diem Michael Craig | Chief Financial Officer | Nov 01, 2023 | Option Exercise | $1.49 | 20,763 | 30,937 | 253,533 | Nov 03, 2023, 04:04 PM |
Borges Luis | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $1.03 | 7,452 | 7,676 | 256,535 | Apr 05, 2023, 04:27 PM |
Borges Luis | Chief Scientific Officer | Mar 23, 2023 | Option Exercise | $1.03 | 220,930 | 227,558 | 264,680 | Mar 23, 2023, 07:31 PM |
Borges Luis | Chief Scientific Officer | Mar 22, 2023 | Option Exercise | $1.03 | 65,698 | 67,669 | 109,448 | Mar 23, 2023, 07:31 PM |
Borges Luis | Chief Scientific Officer | Mar 21, 2023 | Option Exercise | $1.03 | 63,616 | 65,524 | 107,366 | Mar 23, 2023, 07:31 PM |
Borges Luis | Chief Scientific Officer | Mar 23, 2023 | Sale | $3.55 | 15,597 | 55,369 | 249,083 | Mar 23, 2023, 07:31 PM |
Borges Luis | Chief Scientific Officer | Mar 22, 2023 | Sale | $3.72 | 65,698 | 244,640 | 43,750 | Mar 23, 2023, 07:31 PM |
Borges Luis | Chief Scientific Officer | Mar 21, 2023 | Sale | $3.77 | 63,616 | 239,870 | 43,750 | Mar 23, 2023, 07:31 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Aug 09, 2022 | Sale | $13.03 | 550,000 | 7,166,610 | 11,816,814 | Aug 11, 2022, 04:55 PM |
BAYER AKTIENGESELLSCHAFT | 10% Owner | Jun 22, 2021 | Buy | $20.00 | 750,000 | 15,000,000 | 12,675,838 | Jun 23, 2021, 04:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Jun 22, 2021 | Buy | $20.00 | 100,000 | 2,000,000 | 714,095 | Jun 23, 2021, 04:30 PM |
Owner | Relationship | Date | Value($) |
Farid Adrienne | Chief Operations Officer | 03/07/2024 | 23,516 |
Farid Adrienne | Chief Operations Officer | 03/06/2024 | 31,605 |
Farid Adrienne | Chief Operations Officer | 03/07/2024 | 117,342 |
Farid Adrienne | Chief Operations Officer | 03/06/2024 | 152,340 |
Farid Adrienne | Chief Operations Officer | 02/16/2024 | 500 |
Farid Adrienne | Chief Operations Officer | 02/16/2024 | 2,358 |
Carr Douglas | SVP Finance & Operations | 02/06/2024 | 2,499 |
Carr Douglas | SVP Finance & Operations | 02/05/2024 | 2,470 |
Farid Adrienne | Chief Operations Officer | 02/06/2024 | 8,005 |
Farid Adrienne | Chief Operations Officer | 02/05/2024 | 7,816 |
Carr Douglas | SVP Finance & Operations | 11/01/2023 | 24,750 |
Diem Michael Craig | Chief Financial Officer | 11/01/2023 | 30,937 |
Borges Luis | Chief Scientific Officer | 04/03/2023 | 7,676 |
Borges Luis | Chief Scientific Officer | 03/23/2023 | 227,558 |
Borges Luis | Chief Scientific Officer | 03/22/2023 | 67,669 |
Borges Luis | Chief Scientific Officer | 03/21/2023 | 65,524 |
Borges Luis | Chief Scientific Officer | 03/23/2023 | 55,369 |
Borges Luis | Chief Scientific Officer | 03/22/2023 | 244,640 |
Borges Luis | Chief Scientific Officer | 03/21/2023 | 239,870 |
Versant Venture Capital VI, L.P. | 10% Owner | 08/09/2022 | 7,166,610 |
BAYER AKTIENGESELLSCHAFT | 10% Owner | 06/22/2021 | 15,000,000 |
Versant Venture Capital VI, L.P. | 10% Owner | 06/22/2021 | 2,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 1,518,996 | 0.00013% | -4.77% | Other |
BAKER BROS. ADVISORS LP | 797,460 | 0.03% | -30.62% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 468,457 | 0.00016% | 0.81% | Other |
RENAISSANCE TECHNOLOGIES LLC | 119,200 | 0.00061% | 35.92% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View